Impact of transcatheter aortic valve implantation in patients with reduced ejection fraction


Creative Commons License

AYHAN H., KASAPKARA H. A., DURMAZ T., KELEŞ T., Aslan A. N., Sari C., ...Daha Fazla

CARDIOLOGY JOURNAL, cilt.22, sa.1, ss.108-114, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5603/cj.a2014.0040
  • Dergi Adı: CARDIOLOGY JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.108-114
  • Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet

Özet

Background: Aortic stenosis increases with age. According to guidelines, left ventricular systolic dysfunction is an indication for aortic valve replacement, even in asymptomatic patients. There is no clear data on the application of transcatheter aortic valve implantation (TAVI), which is a method showing continuous improvement in recent years, in patients with reduced ejection fraction (REF) having a poor prognosis for surgical aortic valve replacement. We therefore aimed to investigate the effect of TAVI on left ventricular ejection fraction (LVEF) and also its efficacy and safety in patients with REF.